Effects of the CpG motifs with or without HBsAg vaccine on the pregnant mice and their neonates

Zhang Jinping,Xiao Xin,Jiang Jianwei,Liu Xiuxiang
DOI: https://doi.org/10.3969/j.issn.1000-3606.2005.11.020
2005-01-01
Abstract:Objective To observe the influence of CpG_ODN on immune function of pregnant mice and their newborns and investigate if CpG_ODN injection can cause pregnant complications. Methods Serum antibody(IgG) levels in pregnant mice and neonatal mice were determined by ELISA after pregnant mice were immunized by CpG1826. Results CpG1826 increased serum IgG level in non_pregnant adult mice(95.89±14.12 μg/ml vs 15.71±5.64 μg/ml) but did not influence the IgG level in the pregnant mice (10.97±2.14 μg/ml vs 9.28±3.29 μg/ml) and their neonates (1.098±0.32 μg/ml vs 0.856±0.280 μg/ml).With the dose of 20 μg/mouse,no side_effects such as intrauterine growth retardation(IUGR)occurred in the neonates.There was no difference in birth weight (1.471±0.11 g vs 1.489±0.15 g)between the neonates whose mother received CpG1826 or not. Conclusions With the dose of 20 μg/mouse,CpG1826 do not produce any effects of immunological enhancement and any pregnant complications such as IUGR in pregnant mice and their neonates.CpG_ODN as a new immunity adjuvant has large development value and widely clinical application future.
What problem does this paper attempt to address?